[Causes of death and prediction of mortality in COPD].
Solanes Garcia
Ingrid
I
Casan Clarà
Pere
P
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D016535:Bronchial Hyperreactivity / Q000150:complications; D002318:Cardiovascular Diseases / Q000401:mortality; D002423:Cause of Death; D003131:Combined Modality Therapy; D018450:Disease Progression; D017079:Exercise Tolerance; D005541:Forced Expiratory Volume; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000401:mortality; D010102:Oxygen Inhalation Therapy; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000401:mortality* / Q000534:rehabilitation / Q000628:therapy; D011788:Quality of Life; D013030:Spain / Q000453:epidemiology
D000893:Anti-Inflammatory Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors